SOPHiA GENETICS officer plans $10.1K share sale
The notice also lists two earlier 10b5-1 sales of 6,168 shares each, dated September 11 and October 5, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SOPHiA GENETICS SA officer Daan Guido Maria Van Well gave notice of a planned sale of 1,411 common shares, with an approximate sale date of November 9, 2026, and an aggregate market value of $10,074.54. The notice also lists two earlier 10b5-1 sales: 6,168 shares on September 11, 2026, for gross proceeds of $47,088.98, and 6,168 shares on October 5, 2026, for gross proceeds of $50,100.20. The plan adoption date was June 11, 2026.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Restricted Stock Units financial
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.